An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
Editorial by Prof Manolis Tsiknakis, Coordinator of ProCAncer-I project ProCAncer-I project after three years of implementation ProCAncer-I’s vision is to deliver a platform featuring a unique collection of PCa mpMRI images worldwide, in terms of data quantity,...
By Prof. Kai Vilanova. Chief MRI Department. Institute of Biomedical Research of Girona (IDIBGI) Clinical Challenge: Can artificial intelligence based mpMRI with clinical data predict prostate cancer recurrence after prostatectomy? Radical prostatectomy (RP) is a...
By Sara Colantonio, Researcher at ISTI-CNR AI trustworthiness in prostate cancer: where we stand Artificial intelligence (AI) is set to drive groundbreaking medical solutions and services that could transform the diagnosis and treatment in clinical pracise, with...
Interview with Dr. Giacomo Aringhieri, Radiology Research Fellow, Academic Radiology, Department of Translational Research, University of Pisa What is the experience of a young researcher in participating in a European project with great impact on healthcare like...
Partner presentation: Candiolo Cancer Institute, FPO – IRCCS The Candiolo Cancer Institute mission is to give significant contribution to fight cancer, by understanding the basics and providing state-of-the-art diagnostic and therapeutic services. The Institute works...
Partner presentation: CNR – National Research Council of Italy (CNR-ISTI and CNR-IFAC) The National Research Council (CNR) is the main public research organisation in Italy with the aim of carrying out, promoting, disseminating, transferring and improving research...
Newsletter #6 Contents
ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...
Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...
The EUCAIM project is launching an open call for new beneficiaries to join the consortium. The objective of the EUCAIM open call is to: i) onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets, and ii) include...
ProCAncer-I will be organising the 3rd Dissemination Event at the 21st IEEE International Symposium on Biomedical Imaging, which will be held in Athens, Greece, May 27-30, 2024. ProCAncer-I will organise the Workshop “Integrating imaging Data and AI models for...